The power lies in the glycans

被引：0
作者：
Unione, Luca [1 ,2 ]
Jimenez-Barbero, Jesus [1 ,2 ,3 ,4 ]
机构：
[1] Basque Res & Technol Alliance, Ctr Cooperat Res Biosci, Derio, Spain
[2] Basque Fdn Sci, Ikerbasque, Bilbao, Spain
[3] Univ Basque Country, Fac Sci & Technol, Dept Organ & Inorgan Chem, Madrid, Spain
[4] Ctr Invest Biomed Red Enfermedades Respiratorias, Madrid, Spain
来源：
ELIFE | 2024年 / 13卷
关键词：
glycans; natural killer cells; immunotherapy; antibodies; Other; FC-GAMMA-RIII; THERAPEUTIC ANTIBODIES; BINDING;
D O I：
10.7554/eLife.102427
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Glycans play an important role in modulating the interactions between natural killer cells and antibodies to fight pathogens and harmful cells.
引用
收藏
页数：3
相关论文
共 10 条
[1]   Distinct CD16a features on human NK cells observed by flow cytometry correlate with increased ADCC [J].
Benavente, Maria C. Rodriguez ;
Hakeem, Zainab A. ;
Davis, Alexander R. ;
Murray, Nathan B. ;
Azadi, Parastoo ;
Mace, Emily M. ;
Barb, Adam W. .
SCIENTIFIC REPORTS, 2024, 14 (01)
[2]   Inhibiting N-glycan processing increases the antibody binding affinity and effector function of human natural killer cells [J].
Benavente, Maria Carolina Rodriguez ;
Hughes, Harrison B. ;
Kremer, Paul G. ;
Subedi, Ganesh P. ;
Barb, Adam W. .
IMMUNOLOGY, 2023, 170 (02) :202-213
[3]   Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose [J].
Ferrara, Claudia ;
Grau, Sandra ;
Jaeger, Christiane ;
Sondermann, Peter ;
Bruenker, Peter ;
Waldhauer, Inja ;
Hennig, Michael ;
Ruf, Armin ;
Rufer, Arne Christian ;
Stihle, Martine ;
Umana, Pablo ;
Benz, Joerg .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (31) :12669-12674
[4]   One N-glycan regulates natural killer cell antibody-dependent cell-mediated cytotoxicity and modulates Fc γ receptor IIIa/CD16a structure [J].
Kremer, Paul G. ;
Lampros, Elizabeth A. ;
Blocker, Allison M. ;
Barb, Adam W. .
ELIFE, 2024, 13
[5]   Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans [J].
Mizushima, Tsunehiro ;
Yagi, Hirokazu ;
Takemoto, Emi ;
Shibata-Koyama, Mami ;
Isoda, Yuya ;
Iida, Shigeru ;
Masuda, Kazuhiro ;
Satoh, Mitsuo ;
Kato, Koichi .
GENES TO CELLS, 2011, 16 (11) :1071-1080
[6]   Development of NK cell-based cancer immunotherapies through receptor engineering [J].
Page, Audrey ;
Chuvin, Nicolas ;
Valladeau-Guilemond, Jenny ;
Depil, Stephane .
CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (04) :315-331
[7]   Engineering therapeutic antibodies for improved function [J].
Presta, LG ;
Shields, RL ;
Namenuk, AK ;
Hong, K ;
Meng, YG .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :487-490
[8]   Glycosylation in health and disease [J].
Reily, Colin ;
Stewart, Tyler J. ;
Renfrow, Matthew B. ;
Novak, Jan .
NATURE REVIEWS NEPHROLOGY, 2019, 15 (06) :346-366
[9]   Therapeutic Antibodies in Medicine [J].
Sharma, Prerna ;
Joshi, Rahul V. ;
Pritchard, Robert ;
Xu, Kevin ;
Eicher, Maya A. .
MOLECULES, 2023, 28 (18)
[10]   Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity [J].
Shields, RL ;
Lai, J ;
Keck, R ;
O'Connell, LY ;
Hong, K ;
Meng, YG ;
Weikert, SHA ;
Presta, LG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) :26733-26740
1